Citation: B. Nyholm et al., Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus, EXPERT OP I, 10(9), 2001, pp. 1641-1652
Authors:
Orskov, L
Schmitz, O
Bak, JF
Lund, S
Kaal, A
Nyholm, B
Moller, N
Citation: L. Orskov et al., Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects, SC J CL INV, 61(5), 2001, pp. 371-381
Authors:
Rasmussen, BM
Orskov, L
Schmitz, O
Hermansen, K
Citation: Bm. Rasmussen et al., Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects, METABOLISM, 50(4), 2001, pp. 451-457
Authors:
Poulsen, PL
Orskov, L
Grofte, T
Moller, J
Holst, JJ
Schmitz, O
Moller, N
Citation: Pl. Poulsen et al., Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man, METABOLISM, 49(12), 2000, pp. 1598-1603
Authors:
Orskov, L
Nyholm, B
Hove, KY
Gravholt, CH
Moller, N
Schmitz, O
Citation: L. Orskov et al., Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects, DIABET MED, 16(10), 1999, pp. 867-874
Authors:
Nyholm, B
Orskov, L
Hove, KY
Gravholt, CH
Moller, N
Alberti, KGMM
Moyses, C
Kolterman, O
Schmitz, O
Citation: B. Nyholm et al., The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus, METABOLISM, 48(7), 1999, pp. 935-941